Q3 2020 Holdings
Filed 2020-11-16 | 70 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $912.0M | 5,909,742 | 60.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $145.0M | 2,035,132 | 9.6% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $90.4M | 11,329,581 | 6.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $86.7M | 3,672,872 | 5.7% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $78.3M | 2,589,904 | 5.2% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $46.7M | 3,290,000 | 3.1% |
| Alector Inc(ALEC) | COM | 014442107 | $38.1M | 3,618,748 | 2.5% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $36.5M | 2,328,698 | 2.4% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $34.1M | 1,165,184 | 2.3% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $32.9M | 6,260,904 | 2.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $5.2M | 353,072 | 0.3% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $449.1K | 9,011,651 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $264.5K | 4,826,910 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $260.9K | 5,283,818 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $236.2K | 8,825,849 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $168.5K | 5,605,129 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $140.3K | 3,825,008 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $134.5K | 4,750,000 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $129.9K | 1,198,602 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $121.5K | 4,736,214 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $111.4K | 5,140,408 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $110.2K | 4,375,217 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $109.3K | 2,163,271 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $109.0K | 4,417,258 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $98.4K | 5,488,424 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $96.9K | 9,410,860 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $87.6K | 6,162,694 | 0.0% |
| Retrophin Inc | COM | 761299106 | $85.6K | 4,635,687 | 0.0% |
| Kala Pharmaceuticals Inc | COM | 483119103 | $81.6K | 10,874,613 | 0.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $74.3K | 2,408,292 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $72.5K | 982,723 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $72.3K | 1,875,000 | 0.0% |
| Vaxart Inc(VXRT) | COM NEW | 92243A200 | $71.9K | 10,810,937 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $66.0K | 7,775,207 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $60.7K | 1,710,265 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $56.6K | 2,805,045 | 0.0% |
| Inozyme Pharma Inc | COM | 45790W108 | $52.7K | 2,003,653 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $52.4K | 30,126,299 | 0.0% |
| Akouos Inc | COM | 00973J101 | $52.2K | 2,281,249 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $50.6K | 12,315,213 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $42.6K | 1,000,000 | 0.0% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $38.3K | 2,129,003 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $31.8K | 5,100,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $29.4K | 781,290 | 0.0% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $26.2K | 3,518,998 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $25.3K | 7,040,485 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $23.0K | 1,515,151 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $21.3K | 2,118,212 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $20.8K | 2,727,272 | 0.0% |
| Pandion Therapeutics Inc(PAND) | COM | 698340106 | $20.3K | 1,770,023 | 0.0% |